Cargando…
Immune Status of Cervical Lymph Nodes in Head and Neck Cancer—A Surgical Oncology Perspective
Neck dissection for cervical lymph node metastasis is an established procedure for head and neck cancer (HNC). However, with the advent of immunotherapy, head and neck surgical oncologists need to rethink removing all lymph nodes, including those with immune function. We investigated the anti-cancer...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10381643/ https://www.ncbi.nlm.nih.gov/pubmed/37511787 http://dx.doi.org/10.3390/jpm13071174 |
_version_ | 1785080494675722240 |
---|---|
author | Nakamura, Hiromu Ogawa, Tetsuya Yamanaka, Shunpei Inukai, Daisuke Maruo, Takashi Takahara, Taishi Satou, Akira Tsuzuki, Toyonori Suzuki, Susumu Ueda, Ryuzo Fujimoto, Yasushi |
author_facet | Nakamura, Hiromu Ogawa, Tetsuya Yamanaka, Shunpei Inukai, Daisuke Maruo, Takashi Takahara, Taishi Satou, Akira Tsuzuki, Toyonori Suzuki, Susumu Ueda, Ryuzo Fujimoto, Yasushi |
author_sort | Nakamura, Hiromu |
collection | PubMed |
description | Neck dissection for cervical lymph node metastasis is an established procedure for head and neck cancer (HNC). However, with the advent of immunotherapy, head and neck surgical oncologists need to rethink removing all lymph nodes, including those with immune function. We investigated the anti-cancer immune response of the cervical lymph nodes in four patients with human papillomavirus type 16 (HPV16)-positive head and neck squamous cell carcinoma. Using lymphocytes extracted from local, metastatic, and non-metastatic lymph nodes and peripheral blood from these patients, we performed an intracellular flow cytometric cytokine assay using anti-IFNγ and anti-TNF-α monoclonal antibodies to detect HPV16 E6- and E7-specific T cells. HPV status and p16 immunostaining were determined by in situ detection using the HPV RNAscope method and immunohistochemistry. In one case, E6-specific and E7-specific CD8+ T cells were detected in proximal metastatic nodes and distal non-metastatic nodes. This finding suggests that non-metastatic nodes should be preserved for their immune function during neck dissection and that the immune function of non-metastatic lymph nodes is important when administering immunotherapy. In this context, head and neck surgical oncologists treating HNC should consider the place of immunotherapy and neck dissection in the treatment of HNC. |
format | Online Article Text |
id | pubmed-10381643 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-103816432023-07-29 Immune Status of Cervical Lymph Nodes in Head and Neck Cancer—A Surgical Oncology Perspective Nakamura, Hiromu Ogawa, Tetsuya Yamanaka, Shunpei Inukai, Daisuke Maruo, Takashi Takahara, Taishi Satou, Akira Tsuzuki, Toyonori Suzuki, Susumu Ueda, Ryuzo Fujimoto, Yasushi J Pers Med Article Neck dissection for cervical lymph node metastasis is an established procedure for head and neck cancer (HNC). However, with the advent of immunotherapy, head and neck surgical oncologists need to rethink removing all lymph nodes, including those with immune function. We investigated the anti-cancer immune response of the cervical lymph nodes in four patients with human papillomavirus type 16 (HPV16)-positive head and neck squamous cell carcinoma. Using lymphocytes extracted from local, metastatic, and non-metastatic lymph nodes and peripheral blood from these patients, we performed an intracellular flow cytometric cytokine assay using anti-IFNγ and anti-TNF-α monoclonal antibodies to detect HPV16 E6- and E7-specific T cells. HPV status and p16 immunostaining were determined by in situ detection using the HPV RNAscope method and immunohistochemistry. In one case, E6-specific and E7-specific CD8+ T cells were detected in proximal metastatic nodes and distal non-metastatic nodes. This finding suggests that non-metastatic nodes should be preserved for their immune function during neck dissection and that the immune function of non-metastatic lymph nodes is important when administering immunotherapy. In this context, head and neck surgical oncologists treating HNC should consider the place of immunotherapy and neck dissection in the treatment of HNC. MDPI 2023-07-22 /pmc/articles/PMC10381643/ /pubmed/37511787 http://dx.doi.org/10.3390/jpm13071174 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Nakamura, Hiromu Ogawa, Tetsuya Yamanaka, Shunpei Inukai, Daisuke Maruo, Takashi Takahara, Taishi Satou, Akira Tsuzuki, Toyonori Suzuki, Susumu Ueda, Ryuzo Fujimoto, Yasushi Immune Status of Cervical Lymph Nodes in Head and Neck Cancer—A Surgical Oncology Perspective |
title | Immune Status of Cervical Lymph Nodes in Head and Neck Cancer—A Surgical Oncology Perspective |
title_full | Immune Status of Cervical Lymph Nodes in Head and Neck Cancer—A Surgical Oncology Perspective |
title_fullStr | Immune Status of Cervical Lymph Nodes in Head and Neck Cancer—A Surgical Oncology Perspective |
title_full_unstemmed | Immune Status of Cervical Lymph Nodes in Head and Neck Cancer—A Surgical Oncology Perspective |
title_short | Immune Status of Cervical Lymph Nodes in Head and Neck Cancer—A Surgical Oncology Perspective |
title_sort | immune status of cervical lymph nodes in head and neck cancer—a surgical oncology perspective |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10381643/ https://www.ncbi.nlm.nih.gov/pubmed/37511787 http://dx.doi.org/10.3390/jpm13071174 |
work_keys_str_mv | AT nakamurahiromu immunestatusofcervicallymphnodesinheadandneckcancerasurgicaloncologyperspective AT ogawatetsuya immunestatusofcervicallymphnodesinheadandneckcancerasurgicaloncologyperspective AT yamanakashunpei immunestatusofcervicallymphnodesinheadandneckcancerasurgicaloncologyperspective AT inukaidaisuke immunestatusofcervicallymphnodesinheadandneckcancerasurgicaloncologyperspective AT maruotakashi immunestatusofcervicallymphnodesinheadandneckcancerasurgicaloncologyperspective AT takaharataishi immunestatusofcervicallymphnodesinheadandneckcancerasurgicaloncologyperspective AT satouakira immunestatusofcervicallymphnodesinheadandneckcancerasurgicaloncologyperspective AT tsuzukitoyonori immunestatusofcervicallymphnodesinheadandneckcancerasurgicaloncologyperspective AT suzukisusumu immunestatusofcervicallymphnodesinheadandneckcancerasurgicaloncologyperspective AT uedaryuzo immunestatusofcervicallymphnodesinheadandneckcancerasurgicaloncologyperspective AT fujimotoyasushi immunestatusofcervicallymphnodesinheadandneckcancerasurgicaloncologyperspective |